ArticlePLoS pathogens2026
A broad-spectrum phage-encoded mechanism to disarm bacterial type IV filaments.
Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
Abstract
Bacteria-specific viruses, or phages, can modify host cell physiology to thwart competitors. The Pseudomonas aeruginosa-specific phage DMS3 encodes Aqs1, a protein inhibitor of type IV pilus (T4P) function. T4P are important virulence factors widely distributed in bacteria and archaea, but they are also common P. aeruginosa phage receptors. Disabling these structures therefore prevents host cell recognition by other phages that leverage these filaments for infection. Aqs1 disrupts pilus production by binding to PilB, the hexameric ATPase required to power T4P filament extension, though several mechanistic details remain unclear. We show that Aqs1 has broad-spectrum activity and can disrupt T4P ATPase-dependent surface motility, DNA uptake, and protein secretion by binding to PilB homologues in a variety of bacteria. Aqs1 inhibits multiple PilB orthologues by binding to a conserved solvent-exposed hydrophobic patch on its N2-domain, distal to the active site. Binding to this region destabilizes the hexamer, preventing PilB accumulation near T4P machines. We report that a flexible linker segment connecting the PilB N-terminal domains functionally interacts with the Aqs1-binding N2-patch, and that this interaction is required to promote PilB inter-subunit contact. The function of the linker represents a novel element of T4P ATPase allosteric regulation which has been exploited by phages to disrupt diverse functions. The Aqs1 mode-of-action therefore provides a design template for broad-spectrum inhibitors against diverse bacterial virulence factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.